BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$20.71 USD
+1.40 (7.25%)
Updated Jul 11, 2024 11:30 AM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BLFS 20.71 +1.40(7.25%)
Will BLFS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLFS
BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates
Other News for BLFS
Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
Northland Securities Sticks to Their Buy Rating for BioLife Solutions (BLFS)
Top 4 July Stocks: Hot Month For S&P 500 (SA Quant)
BioLife Solutions (BLFS) Receives a Buy from Craig-Hallum
BioLife Solutions Introduces the CellSeal CryoCaseâ„¢ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver